Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23499158 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients
Condition: Hepatitis C Virus
Interventions: Drug: Sofosbuvir;   Drug: Placebo to match sofosbuvir;   Drug: PEG;   Drug: RBV

Indicates status has not been verified in more than two years